Regulatory Articles

  1. Sustainable Catalysis 6/18/2026

    Catalyst selection is vital for green chemistry. Balancing efficiency and environmental impact requires smart decisions to advance sustainable synthetic methods without losing performance.

  2. Navigating The Challenges Of AI/ML In R&D 6/18/2026

    AI progress is stalled by fragmented, low-quality data, not technology. Standardization, automation, and cultural change transform disconnected datasets into a foundation for smarter decisions.

  3. Get Smoother Separations, Faster: Troubleshoot Method Development 6/18/2026

    Strong chromatography requires more than separation. Fine-tuning pH, columns, and system volume prevents poor peak shape, while modeling tools streamline optimization for reproducible results.

  4. Unlock The Full Potential Of Your Chromatography Data Systems 6/18/2026

    Chromatography Data Systems centralize instrument control and data management to boost lab accuracy and compliance. Automation enables reliable, high-throughput performance across regulated workflows.

  5. How To Benchmark Your Digital Transformation Performance And AI-Readiness 6/18/2026

    AI investment is rising across life sciences, but data challenges stall real-world adoption. Discover what is holding teams back and how to turn AI potential into practical scientific impact.

  6. The History Of Chemical Nomenclature And ACD/Name 6/18/2026

    Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.

  7. Aligning Standards, Validation, And Governance For Digital Preclinical Research 6/18/2026

    No single body integrates preclinical data components into a coherent discipline supported by shared standards, common terminology, and collective accountability.

  8. FDA's New Oncology Guidance Signals The Next Phase Of Drug Development Reform 6/2/2026

    New FDA guidance encourages streamlined nonclinical safety assessments for certain cancer therapies and explicitly seeks to reduce unnecessary animal testing while maintaining patient safety.

  9. Executive Order For Psychedelics 5/8/2026

    We caught up with Joseph Tucker, Ph.D., CEO of Enveric Biosciences, to discuss the executive order for psychedelics.

  10. U.S. Pharma Tariffs And MFN Become Law After April 2 Update 4/15/2026

    Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.